Structure Therapeutics Inc.

Structure Therapeutics Inc. conducts clinical research in healthy participants, with a focus on early human assessment of pharmacokinetics, metabolism, and excretion. Its research activity centers on understanding how investigational compounds behave in the body under controlled conditions.

• Mass balance studies
• Pharmacokinetic profiling
• Metabolic and elimination pathways

The sponsor’s current clinical activity is concentrated in a single recruiting study in the United States, reflecting an interest in foundational human pharmacology and drug disposition.